Terms: = Bone cancer AND YWHAE, P62258, 7531, ENSG00000108953, 14-3-3 epsilon, FLJ45465, MDS, MDCR, KCIP-1, 14-3-3E
1905 results:
1. [Pathogenesis of myelodysplastic syndromes by excessive mitochondrial fragmentation].
Hayashi Y
Rinsho Ketsueki; 2024; 65(4):249-254. PubMed ID: 38684435
[TBL] [Abstract] [Full Text] [Related]
2. Germline
Panagopoulos I; Andersen K; Stavseth V; Torkildsen S; Heim S; Tandsæther MR
Cancer Genomics Proteomics; 2024; 21(3):272-284. PubMed ID: 38670586
[TBL] [Abstract] [Full Text] [Related]
3. Myelodysplastic Neoplasms (mds): The Current and Future Treatment Landscape.
Karel D; Valburg C; Woddor N; Nava VE; Aggarwal A
Curr Oncol; 2024 Apr; 31(4):1971-1993. PubMed ID: 38668051
[TBL] [Abstract] [Full Text] [Related]
4. Myelodysplastic Neoplasms (mds) with Ring Sideroblasts or
Mortuza S; Chin-Yee B; James TE; Chin-Yee IH; Hedley BD; Ho JM; Saini L; Lazo-Langner A; Schenkel L; Bhai P; Sadikovic B; Keow J; Sangle N; Hsia CC
Curr Oncol; 2024 Mar; 31(4):1762-1773. PubMed ID: 38668037
[TBL] [Abstract] [Full Text] [Related]
5. A novel t(X;21)(p11.4;q22.12) translocation adds to the role of BCOR and RUNX1 in myelodysplastic syndromes and acute myeloid leukemias.
Mavridou E; Lema Fernandez AG; Nardelli C; Pierini V; Quintini M; Arniani S; Di Giacomo D; Crescenzi B; Matteucci C; Sambani C; Mecucci C
Genes Chromosomes Cancer; 2024 Apr; 63(4):e23235. PubMed ID: 38656651
[TBL] [Abstract] [Full Text] [Related]
6. Caspase 8 deletion causes infection/inflammation-induced bone marrow failure and mds-like disease in mice.
Liu S; Joshi K; Zhang L; Li W; Mack R; Runde A; Hagen PA; Barton K; Breslin P; Ji HL; Kini AR; Wang Z; Zhang J
Cell Death Dis; 2024 Apr; 15(4):278. PubMed ID: 38637559
[TBL] [Abstract] [Full Text] [Related]
7. Donor
Schetelig J; Baldauf H; Heidenreich F; Hoogenboom JD; Spellman SR; Kulagin A; Schroeder T; Sengeloev H; Dreger P; Forcade E; Vydra J; Wagner-Drouet EM; Choi G; Paneesha S; Miranda NAA; Tanase A; de Wreede LC; Lange V; Schmidt AH; Sauter J; Fein JA; Bolon YT; He M; Marsh SGE; Gadalla SM; Paczesny S; Ruggeri A; Chabannon C; Fleischhauer K
Front Immunol; 2024; 15():1350470. PubMed ID: 38629074
[TBL] [Abstract] [Full Text] [Related]
8. Comparison of the 2022 world health organization classification and international consensus classification in myelodysplastic syndromes/neoplasms.
Lee WH; Lin CC; Tsai CH; Tien FM; Lo MY; Tseng MH; Kuo YY; Yu SC; Liu MC; Yuan CT; Yang YT; Chuang MK; Ko BS; Tang JL; Sun HI; Chuang YK; Tien HF; Hou HA; Chou WC
Blood Cancer J; 2024 Apr; 14(1):57. PubMed ID: 38594285
[TBL] [Abstract] [Full Text] [Related]
9. Gene expression patterns of Sirtuin family members (SIRT1 TO SIRT7): Insights into pathogenesis and prognostic of Myelodysplastic neoplasm.
Goes JVC; Viana MA; Sampaio LR; Cavalcante CBA; Melo MML; de Oliveira RTG; Borges DP; Gonçalves PG; Pinheiro RF; Ribeiro-Junior HL
Gene; 2024 Jul; 915():148428. PubMed ID: 38575099
[TBL] [Abstract] [Full Text] [Related]
10. [Efficacy and prognostic factors of allogeneic hematopoietic stem cell transplantation in the treatment of secondary acute myeloid leukemia].
Yuan XL; Wu YB; Song XL; Chen Y; Lu Y; Lai XY; Shi JM; Liu LZ; Zhao YM; Yu J; Yang LX; Lan JP; Cai Z; Huang H; Luo Y
Zhonghua Xue Ye Xue Za Zhi; 2024 Jan; 45(1):41-47. PubMed ID: 38527837
[No Abstract] [Full Text] [Related]
11. HSPA9/mortalin inhibition disrupts erythroid maturation through a TP53-dependent mechanism in human CD34+ hematopoietic progenitor cells.
Butler C; Dunmire M; Choi J; Szalai G; Johnson A; Lei W; Chen X; Liu L; Li W; Walter MJ; Liu T
Cell Stress Chaperones; 2024 Apr; 29(2):300-311. PubMed ID: 38508444
[TBL] [Abstract] [Full Text] [Related]
12. Prognostic impact of the bone marrow tumor microenvironment, HLA-I and HLA-Ib expression in mds and CMML progression to sAML.
Bauer M; Jäkel N; Wilfer A; Haak A; Eszlinger M; Kelemen K; Haemmerle M; Al-Ali HK; Seliger B; Wickenhauser C
Oncoimmunology; 2024; 13(1):2323212. PubMed ID: 38481730
[TBL] [Abstract] [Full Text] [Related]
13. Reduced toxicity matched sibling bone marrow transplant results in excellent outcomes for severe congenital neutropenia.
Oved JH; Gibson NM; Venella K; Elgarten CW; Wray L; Warren JT; Olson TS
Front Immunol; 2024; 15():1369243. PubMed ID: 38469307
[TBL] [Abstract] [Full Text] [Related]
14. Myelodysplastic Syndromes and Myelodysplastic Syndromes/Myeloproliferative Neoplasms: A Real-World Experience From a Developing Country.
Awidi A; Alzu'bi M; Odeh N; Alrawabdeh J; Al Zyoud M; Hamadneh Y; Bawa'neh H; Magableh A; Alshorman A; Al-Fararjeh F; Aladily T; Zeidan AM
JCO Glob Oncol; 2024 Feb; 10():e2300281. PubMed ID: 38422464
[TBL] [Abstract] [Full Text] [Related]
15. TP53 in mds and AML: Biological and clinical advances.
Zhao Y; Chen W; Yu J; Pei S; Zhang Q; Shi J; Huang H; Zhao Y
Cancer Lett; 2024 Apr; 588():216767. PubMed ID: 38417666
[TBL] [Abstract] [Full Text] [Related]
16. Treatment with the apoptosis inhibitor Asunercept reduces clone sizes in patients with lower risk Myelodysplastic Neoplasms.
Streuer A; Jann JC; Boch T; Mossner M; Riabov V; Schmitt N; Altrock E; Xu Q; Demmerle M; Nowak V; Oblaender J; Palme I; Weimer N; Rapp F; Metzgeroth G; Hecht A; Höger T; Merz C; Hofmann WK; Nolte F; Nowak D
Ann Hematol; 2024 Apr; 103(4):1221-1233. PubMed ID: 38413410
[TBL] [Abstract] [Full Text] [Related]
17. Ectopic expression of the transcription factor ONECUT3 drives a complex karyotype in myelodysplastic syndromes.
Luo Y; Feng X; Lang W; Xu W; Wang W; Mei C; Ye L; Zhu S; Wang L; Zhou X; Zeng H; Ma L; Ren Y; Jin J; Xu R; Huang G; Tong H
J Clin Invest; 2024 Feb; 134(8):. PubMed ID: 38386414
[TBL] [Abstract] [Full Text] [Related]
18. [bone marrow histology of cytopenias : Contribution to hematological differential diagnosis].
Kreipe H
Pathologie (Heidelb); 2024 Mar; 45(2):148-158. PubMed ID: 38381371
[TBL] [Abstract] [Full Text] [Related]
19. Efficacy of novel agents against cellular models of familial platelet disorder with myeloid malignancy (FPD-MM).
Mill CP; Fiskus WC; DiNardo CD; Reville P; Davis JA; Birdwell CE; Das K; Hou H; Takahashi K; Flores L; Ruan X; Su X; Loghavi S; Khoury JD; Bhalla KN
Blood Cancer J; 2024 Feb; 14(1):25. PubMed ID: 38316746
[TBL] [Abstract] [Full Text] [Related]
20. Myelodysplastic neoplasms evolving from inherited bone marrow failure syndromes / germline predisposition syndromes: Back under the microscope.
Elghetany MT; Patnaik MM; Khoury JD
Leuk Res; 2024 Feb; 137():107441. PubMed ID: 38301422
[TBL] [Abstract] [Full Text] [Related]
[Next]